Dobrinas, M., Cornuz, J., Oneda, B. et al. : Impact of smoking, smoking cessation, and genetic polymorphisms on CYP1A2 activity and inducibility. Clin. Pharmacol. Ther., 90 : 117-125, 2011.
Food and Drug Administration : Prescribing Information for INVEGA (Paliperidone). 2006. Available online : https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021999s018lbl.pdf (accessed on 30 June 2021)
Hiemke, C., Bergemann, N., Clement, H.W. et al. : Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology : Update 2017. Pharmacopsychiatry, 51 : 9-62, 2018.
Jukić, M.M., Haslemo, T., Molden, E. et al. : Impact of CYP2C19 Genotype on Escitalopram Exposure and Therapeutic Failure : A Retrospective Study Based on 2,087 Patients. Am. J. Psychiatry, 175 : 463-470, 2018.
Jukic, M.M., Smith, R.L., Haslemo, T. et al. : Effect of CYP2D6 genotype on exposure and efficacy of risperidone and aripiprazole : A retrospective, cohort study. Lancet Psychiatry, 6 : 418-426, 2019.